Bernard Haendler

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 28

Top Topics

Benign Prostatic Hyperplasia

Top Venues

International journal of molecular sciences

Molecular oncology

Clinical cancer research : an official journal of the American Association for Cancer Research

This page only lists publications with an associated author ORCID identifier.

Publications

Christoph A Schatz, Sabine Zitzmann-Kolbe, Ingrid Moen, Monika Klotz, Shankari Nair, Stefan Stargard, Roger M Bjerke, Katrine Wickstrøm Biseth, Yuan Zeng Feng, Bård Indrevoll, Véronique Cruciani, Jenny Karlsson, Bernard Haendler, Carsten H Nielsen, Maria Z Alfsen, Stefanie Hammer, Hartwig Hennekes, Alan S Cuthbertson, Urs B Hagemann, Aasmund Larsen
Preclinical Efficacy of a PSMA-Targeted Actinium-225 Conjugate (225Ac-Macropa-Pelgifatamab): A Targeted Alpha Therapy for Prostate Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (11) (2024)
Paulina J Dziubańska-Kusibab, Ekaterina Nevedomskaya, Bernard Haendler
Preclinical Anticipation of On- and Off-Target Resistance Mechanisms to Anti-Cancer Drugs: A Systematic Review. International journal of molecular sciences 25 (2) (2024)
Christoph A Schatz, Sabine Zitzmann-Kolbe, Ingrid Moen, Monika Klotz, Shankari Nair, Stefan Stargard, Roger M Bjerke, Katrine Wickstrøm Biseth, Yuan Zeng Feng, Bård Indrevoll, Véronique Cruciani, Jenny Karlsson, Bernard Haendler, Carsten H Nielsen, Maria Z Alfsen, Stefanie Hammer, Hartwig Hennekes, Alan S Cuthbertson, Urs B Hagemann, Aasmund Larsen
Preclinical efficacy of a PSMA-targeted actinium-225 conjugate (225Ac-macropa-pelgifatamab) - a targeted alpha therapy for prostate cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Tatsuo Sugawara, Ekaterina Nevedomskaya, Simon Heller, Annika Böhme, Ralf Lesche, Oliver von Ahsen, Sylvia Grünewald, Holly M Nguyen, Eva Corey, Simon J Baumgart, Victoria Georgi, Vera Pütter, Amaury Fernández-Montalván, James D Vasta, Matthew B Robers, Oliver Politz, Dominik Mumberg, Bernard Haendler
Dual targeting of the androgen receptor and PI3K/AKT/mTOR pathways in prostate cancer models improves antitumor efficacy and promotes cell apoptosis. Molecular oncology 18 (3) (2024)
Paulina J Dziubańska-Kusibab, Ekaterina Nevedomskaya, Bernard Haendler
Preclinical Anticipation of On- and Off-Target Resistance Mechanisms to Anti-Cancer Drugs: A Systematic Review. International journal of molecular sciences 25 (2) (2024)
Paulina J Dziubańska-Kusibab, Ekaterina Nevedomskaya, Bernard Haendler
Preclinical Anticipation of On- and Off-Target Resistance Mechanisms to Anti-Cancer Drugs: A Systematic Review. International journal of molecular sciences 25 (2) (2024)
Tatsuo Sugawara, Ekaterina Nevedomskaya, Simon Heller, Annika Böhme, Ralf Lesche, Oliver von Ahsen, Sylvia Grünewald, Holly M Nguyen, Eva Corey, Simon J Baumgart, Victoria Georgi, Vera Pütter, Amaury Fernández-Montalván, James D Vasta, Matthew B Robers, Oliver Politz, Dominik Mumberg, Bernard Haendler
Dual targeting of the androgen receptor and PI3K/AKT/mTOR pathways in prostate cancer models improves antitumor efficacy and promotes cell apoptosis. Molecular oncology 18 (3) (2024)
Paulina J Dziubańska-Kusibab, Ekaterina Nevedomskaya, Bernard Haendler
Preclinical Anticipation of On- and Off-Target Resistance Mechanisms to Anti-Cancer Drugs: A Systematic Review. International journal of molecular sciences 25 (2) (2024)
Tatsuo Sugawara, Ekaterina Nevedomskaya, Simon Heller, Annika Böhme, Ralf Lesche, Oliver von Ahsen, Sylvia Grünewald, Holly M Nguyen, Eva Corey, Simon J Baumgart, Victoria Georgi, Vera Pütter, Amaury Fernández-Montalván, James D Vasta, Matthew B Robers, Oliver Politz, Dominik Mumberg, Bernard Haendler
Dual targeting of the androgen receptor and PI3K/AKT/mTOR pathways in prostate cancer models improves antitumor efficacy and promotes cell apoptosis. Molecular oncology 18 (3) (2024)
Tatsuo Sugawara, Ekaterina Nevedomskaya, Simon Heller, Annika Böhme, Ralf Lesche, Oliver von Ahsen, Sylvia Grünewald, Holly M Nguyen, Eva Corey, Simon J Baumgart, Victoria Georgi, Vera Pütter, Amaury Fernández-Montalván, James D Vasta, Matthew B Robers, Oliver Politz, Dominik Mumberg, Bernard Haendler
Dual targeting of the androgen receptor and PI3K/AKT/mTOR pathways in prostate cancer models improves antitumor efficacy and promotes cell apoptosis. Molecular oncology 18 (3) (2024)
Tatsuo Sugawara, Ekaterina Nevedomskaya, Simon Heller, Annika Böhme, Ralf Lesche, Oliver von Ahsen, Sylvia Grünewald, Holly M Nguyen, Eva Corey, Simon J Baumgart, Victoria Georgi, Vera Pütter, Amaury Fernández-Montalván, James D Vasta, Matthew B Robers, Oliver Politz, Dominik Mumberg, Bernard Haendler
Dual targeting of the androgen receptor and PI3K/AKT/mTOR pathways in prostate cancer models improves antitumor efficacy and promotes cell apoptosis. Molecular oncology (2024)
Christoph A Schatz, Sabine Zitzmann-Kolbe, Ingrid Moen, Monika Klotz, Shankari Nair, Stefan Stargard, Roger M Bjerke, Katrine Wickstrøm Biseth, Yuan Zeng Feng, Bård Indrevoll, Véronique Cruciani, Jenny Karlsson, Bernard Haendler, Carsten H Nielsen, Maria Z Alfsen, Stefanie Hammer, Hartwig Hennekes, Alan S Cuthbertson, Urs B Hagemann, Aasmund Larsen
Preclinical Efficacy of a PSMA-Targeted Actinium-225 Conjugate (225Ac-Macropa-Pelgifatamab): A Targeted Alpha Therapy for Prostate Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (11) (2024)
Mari I Suominen, Matthias Ocker, Christoph A Schatz, Andreas Schlicker, Jukka Vääräniemi, Birgitta Sjöholm, Esa Alhoniemi, Bernard Haendler, Dominik Mumberg, Sanna-Maria Käkönen, Arne Scholz
Enhanced Antitumor Efficacy of Radium-223 and Enzalutamide in the Intratibial LNCaP Prostate Cancer Model. International journal of molecular sciences 24 (3) (2023)
Mari I Suominen, Matthias Ocker, Christoph A Schatz, Andreas Schlicker, Jukka Vääräniemi, Birgitta Sjöholm, Esa Alhoniemi, Bernard Haendler, Dominik Mumberg, Sanna-Maria Käkönen, Arne Scholz
Enhanced Antitumor Efficacy of Radium-223 and Enzalutamide in the Intratibial LNCaP Prostate Cancer Model. International journal of molecular sciences 24 (3) (2023)
Fabio Raith, Daniel H O'Donovan, Clara Lemos, Oliver Politz, Bernard Haendler
Addressing the Reciprocal Crosstalk between the AR and the PI3K/AKT/mTOR Signaling Pathways for Prostate Cancer Treatment. International journal of molecular sciences 24 (3) (2023)
Fabio Raith, Daniel H O'Donovan, Clara Lemos, Oliver Politz, Bernard Haendler
Addressing the Reciprocal Crosstalk between the AR and the PI3K/AKT/mTOR Signaling Pathways for Prostate Cancer Treatment. International journal of molecular sciences 24 (3) (2023)
Fabio Raith, Daniel H O'Donovan, Clara Lemos, Oliver Politz, Bernard Haendler
Addressing the Reciprocal Crosstalk between the AR and the PI3K/AKT/mTOR Signaling Pathways for Prostate Cancer Treatment. International journal of molecular sciences 24 (3) (2023)
Mari I Suominen, Matthias Ocker, Christoph A Schatz, Andreas Schlicker, Jukka Vääräniemi, Birgitta Sjöholm, Esa Alhoniemi, Bernard Haendler, Dominik Mumberg, Sanna-Maria Käkönen, Arne Scholz
Enhanced Antitumor Efficacy of Radium-223 and Enzalutamide in the Intratibial LNCaP Prostate Cancer Model. International journal of molecular sciences 24 (3) (2023)
Ekaterina Nevedomskaya, Tatsuo Sugawara, Simon J Baumgart, Ralf Lesche, Hannes Hahne, Dominik Mumberg, Bernard Haendler
Comparative Proteomic and Transcriptomic Analysis of the Impact of Androgen Stimulation and Darolutamide Inhibition. Cancers 15 (1) (2022)
Ekaterina Nevedomskaya, Tatsuo Sugawara, Simon J Baumgart, Ralf Lesche, Hannes Hahne, Dominik Mumberg, Bernard Haendler
Comparative Proteomic and Transcriptomic Analysis of the Impact of Androgen Stimulation and Darolutamide Inhibition. Cancers 15 (1) (2022)
Ekaterina Nevedomskaya, Bernard Haendler
From Omics to Multi-Omics Approaches for In-Depth Analysis of the Molecular Mechanisms of Prostate Cancer. International journal of molecular sciences 23 (11) (2022)
Ekaterina Nevedomskaya, Tatsuo Sugawara, Simon J Baumgart, Ralf Lesche, Hannes Hahne, Dominik Mumberg, Bernard Haendler
Comparative Proteomic and Transcriptomic Analysis of the Impact of Androgen Stimulation and Darolutamide Inhibition. Cancers 15 (1) (2022)
Stefanie Hammer, Andreas Schlicker, Sabine Zitzmann-Kolbe, Simon Baumgart, Urs B Hagemann, Arne Scholz, Bernard Haendler, Pascale Lejeune, Jenny Karlsson, Christine Ellingsen, Hartwig Hennekes, Carsten H Nielsen, Mark U Juul, Dominik Mumberg, Christoph A Schatz
Darolutamide Potentiates the Antitumor Efficacy of a PSMA-targeted Thorium-227 Conjugate by a Dual Mode of Action in Prostate Cancer Models. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (15) (2021)
Clara Lemos, Volker K Schulze, Simon J Baumgart, Ekaterina Nevedomskaya, Tobias Heinrich, Julien Lefranc, Benjamin Bader, Clara D Christ, Hans Briem, Lara P Kuhnke, Simon J Holton, Ulf Bömer, Philip Lienau, Franz von Nussbaum, Carl F Nising, Marcus Bauser, Andrea Hägebarth, Dominik Mumberg, Bernard Haendler
The potent AMPK inhibitor BAY-3827 shows strong efficacy in androgen-dependent prostate cancer models. Cellular oncology (Dordrecht) 44 (3) (2021)
Simon J Baumgart, Ekaterina Nevedomskaya, Ralf Lesche, Richard Newman, Dominik Mumberg, Bernard Haendler
Darolutamide antagonizes androgen signaling by blocking enhancer and super-enhancer activation. Molecular oncology 14 (9) (2020)
Antje M Wengner, Arne Scholz, Bernard Haendler
Targeting DNA Damage Response in Prostate and Breast Cancer. International journal of molecular sciences 21 (21) (2020)
Tatsuo Sugawara, Simon J Baumgart, Ekaterina Nevedomskaya, Kristin Reichert, Holger Steuber, Pascale Lejeune, Dominik Mumberg, Bernard Haendler
Darolutamide is a potent androgen receptor antagonist with strong efficacy in prostate cancer models. International journal of cancer 145 (5) (2019)
Simon J Baumgart, Ekaterina Nevedomskaya, Bernard Haendler
Dysregulated Transcriptional Control in Prostate Cancer. International journal of molecular sciences 20 (12) (2019)